EndoStim Patient Registry
- Conditions
- GERD
- Registration Number
- NCT02441400
- Lead Sponsor
- EndoStim Inc.
- Brief Summary
To provide a research tool enabling physicians to monitor long term clinical outcomes for patients undergoing gastroesophageal reflux disease (GERD) treatment with EndoStim LES Stimulation System.
- Detailed Description
The EndoStim Patient Registry provides a framework for data collection on patients with GERD treated with the EndoStim LES Stimulation System. The primary objective is to provide a tool for participating physician investigators to collect and analyze outcomes data related to the use of the EndoStim LES Stimulation System.
This is a prospective, multi-center patient Registry. Sites may choose to also retrospectively enroll previously treated patients (after obtaining informed consent) and enter retrospective data into case report forms paper or on-line.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 350
- Subject meets therapy indications
- Subject signs informed consent
- Subject has a planned EndoStim LES Stimulation System implant (prospective) OR subject has already had EndoStim LES Stimulation System implant (retrospective)
- Subject meets therapy contraindications
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and severity of adverse events 5 years post-implant Safety will be assessed by incidence and severity of adverse events through 5 years of follow-up
- Secondary Outcome Measures
Name Time Method Change in GERD-HRQL Change in GERD-HRQL questionnaire score will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline GERD-HRQL
Comparison of pH values The pH values of % 24-hour esophageal pH < 4.0, and the number of reflux events > 1 minute and > 5 minutes will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in the following (while off PPI): % 24-hour esophageal pH\<4.0, and number of reflux events \>1 minute and \> 5 minutes
Comparison of symptoms and quality of life Symptoms will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in symptoms (measured by patient diary) and in quality of life (measured by SF-12)
Change in antisecretory medication use The use of antisecretory medication will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in antisecretory medication use
Change in Structured GI Questionnaire responses (vs. baseline) Symptoms will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline on Structured GI Questionnaire responses
Change in sleep related quality of life Sleep related quality of life will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in sleep related quality of life (measured by Pittsburgh Sleep Quality Index)
Change in work productivity impairment Work productivity will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in work productivity impairment (measured by Work Productivity and Activity Impairment Questionnaire)
Change in Reflux Disease Questionnaire (RDQ) scores RDQ questionnaire score will be assessed at baseline, 3-6 months post implant, and then annually until 5 years Change from baseline in RDQ scores
Trial Locations
- Locations (30)
Fundacion Favaloro
🇦🇷Buenos Aires, Argentina
University Hospital Vienna
🇦🇹Vienna, Austria
Aarhus University Hospital
🇩🇰Aarhus, Denmark
SANA Klinikum Lichtenberg
🇩🇪Berlin, Germany
Evangelisches Krankenhaus Castrop-Rauxel
🇩🇪Castrop Rauxel, Germany
St. Marienstift Krankenhaus Friesoythe
🇩🇪Friesoythe, Germany
Hospital zum Heiligen Geist Fritzlar
🇩🇪Fritzlar, Germany
Klinikum Garmisch-Partenkirchen
🇩🇪Garmisch-Partenkirchen, Germany
Wolfartklinik Graefelfing
🇩🇪Gräfelfing, Germany
Martha Maria Krankenhaus Halle-Dölau
🇩🇪Halle, Germany
Scroll for more (20 remaining)Fundacion Favaloro🇦🇷Buenos Aires, Argentina